摘要
目的:探讨超声联合血清中核因子-κB(NF-κB)的检测对乳腺癌患者的诊断价值及其临床应用效果。方法:选取2016年5月-2017年5月笔者所在医院收治的乳腺癌患者55例为研究组,选择同时期笔者所在医院收治的良性乳腺疾病患者55例为对照组。比较两组NF-κB、癌抗原15-3(CA15-3)水平,超声、NF-κB及超声联合NF-κB检测乳腺癌的检出率。结果:研究组的NF-κB、CA15-3水平均高于对照组,差异有统计学意义(P<0.05)。超声联合NF-κB检测乳腺癌的检出率均高于超声检测及NF-κB检测的检出率,差异有统计学意义(P<0.05)。结论:超声联合NF-κB检测乳腺癌的检出率更高,临床检测乳腺癌价值较高。
Objective:To investigate the diagnostic value and clinical application of ultrasound combined with serum nuclear factor-kappa B(NF-κB detection in breast cancer patients.Method:A total of 55 cases of breast cancer patients admitted to our hospital from May 2016 to May 2017 were selected as the study group,and 55 cases of benign breast disease patients admitted to our hospital during the same period were selected as the control group.The levels of NF-κB and cancer antigen 15-3(CA15-3)were compared between the two groups.The detection rate of breast cancer was detected by ultrasound,NF-κB and ultrasound combined with NF-κB.Result:The levels of NF-κB and CA15-3 in the study group were higher than those in the control group,and the differences were statistically significant(P<0.05).The detection rate of breast cancer detected by ultrasound combined with NF-κB was higher than that of ultrasound detection and NF-κB detection,and the difference was statistically significant(P<0.05).Conclusion:The detection rate of breast cancer by ultrasound combined with NF-κB is higher,and the value of clinical detection of breast cancer is higher.
作者
杨力云
YANG Liyun(Yidu First People’s Hospital,Yidu 443300,China)
出处
《中外医学研究》
2019年第22期56-58,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
关键词
超声
核因子-ΚB
乳腺癌
价值
应用
Ultrasound
Nuclear factor-kappa B
Breast cancer
Value
Application